|
Rontalizumab is a humanized monoclonal antibody〔(WHO Drug Information )〕 being developed by Genentech.〔(Genentech: Rontalizumab (rhuMAb IFN alpha) )〕 , it is being investigated in a clinical trial or the treatment of systemic lupus erythematosus. ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Rontalizumab」の詳細全文を読む スポンサード リンク
|